- Home
- TOPS vs COCH Comparison
TOPS vs COCH Comparison
Compare TOPS & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPS
- COCH
- Stock Information
- Founded
- TOPS 2000
- COCH 1995
- Country
- TOPS Greece
- COCH United States
- Employees
- TOPS N/A
- COCH N/A
- Industry
- TOPS Marine Transportation
- COCH Blank Checks
- Sector
- TOPS Consumer Discretionary
- COCH Finance
- Exchange
- TOPS Nasdaq
- COCH Nasdaq
- Market Cap
- TOPS 27.4M
- COCH 31.6M
- IPO Year
- TOPS 2004
- COCH N/A
- Fundamental
- Price
- TOPS $5.90
- COCH $1.50
- Analyst Decision
- TOPS
- COCH Strong Buy
- Analyst Count
- TOPS 0
- COCH 2
- Target Price
- TOPS N/A
- COCH $9.25
- AVG Volume (30 Days)
- TOPS 110.7K
- COCH 20.0K
- Earning Date
- TOPS 08-08-2025
- COCH 08-11-2025
- Dividend Yield
- TOPS N/A
- COCH N/A
- EPS Growth
- TOPS N/A
- COCH N/A
- EPS
- TOPS 1.09
- COCH N/A
- Revenue
- TOPS $86,127,000.00
- COCH $212,000.00
- Revenue This Year
- TOPS $9.90
- COCH $8.04
- Revenue Next Year
- TOPS N/A
- COCH $15.39
- P/E Ratio
- TOPS $5.42
- COCH N/A
- Revenue Growth
- TOPS 3.83
- COCH N/A
- 52 Week Low
- TOPS $5.00
- COCH $1.21
- 52 Week High
- TOPS $11.47
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- TOPS 46.93
- COCH 57.76
- Support Level
- TOPS $5.74
- COCH $1.40
- Resistance Level
- TOPS $6.00
- COCH $1.58
- Average True Range (ATR)
- TOPS 0.47
- COCH 0.08
- MACD
- TOPS -0.04
- COCH 0.01
- Stochastic Oscillator
- TOPS 37.71
- COCH 100.00
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco tanker vessels focusing on the transportation of crude oil, petroleum products (clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.